Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression

Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression

US Patent 12091675 · Granted Sep 17, 2024

Estimated economic value: $45,628,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-factor IX padua antibodies2024
Subcutaneous administration of ADAMTS132023
Subcutaneous administration of ADAMTS132023
Viral vectors encoding recombinant FVIII variants with increased expression for 2023
Gene therapy of hemophilia B using viral vectors encoding recombinant fix varian2023
Nucleophilic catalysts for oxime linkage2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Subcutaneous administration of ADAMTS132021
Anti-factor IX Padua antibodies2021
Blood coagulation protein conjugates2021
Methods for testing effectiveness of a von Willebrand factor used in treating vo2021